Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.
Marusiak AA, Prelowska MK, Mehlich D, Lazniewski M, Kaminska K, Gorczynski A, Korwat A, Sokolowska O, Kedzierska H, Golab J, Biernat W, Plewczynski D, Brognard J, Nowis D.
Oncogene, 2018 Dec 14
https://www.ncbi.nlm.nih.gov/pubmed/30552384
Inhibition of thioredoxin-dependent H2O2 removal sensitizes malignant B-cells to pharmacological ascorbate.
Graczyk-Jarzynka A, Goral A, Muchowicz A, Zagozdzon R, Winiarska M, Bajor M, Trzeciecka A, Fidyt K, Krupka JA, Cyran J, Szczygiel K, Efremov DG, Gobessi S, Jagielski A, Siudakowska K, Bobrowicz M, Klopotowska M, Barankiewicz J, Malenda A, Lech-Maranda E, Miazek-Zapala N, Skarzynski PH, Domagala A, Golab J, Firczuk M.
Redox Biol. 2018 Nov 29
https://www.ncbi.nlm.nih.gov/pubmed/30576925
Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents.
Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, Siedlecki P, Kniotek M, O'Leary PC, Golab J, Zagozdzon R.
Br J Cancer. 2018 Oct
https://www.ncbi.nlm.nih.gov/pubmed/30287919
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
Eustace AJ, Conlon NT, McDermott MSJ, Browne BC, O'Leary P, Holmes FA, Espina V, Liotta LA, O'Shaughnessy J, Gallagher C, O'Driscoll L, Rani S, Madden SF, O'Brien NA, Ginther C, Slamon D, Walsh N, Gallagher WM, Zagozdzon R, Watson WR, O'Donovan N, Crown J.
BMC Cancer. 2018 Oct 11
https://www.ncbi.nlm.nih.gov/pubmed/30305055
Intraurethral co-transplantation of bone marrow mesenchymal stem cells and muscle-derived cells improves the urethral closure.
Burdzinska A, Dybowski B, Zarychta-Wiśniewska W, Kulesza A, Butrym M, Zagozdzon R, Graczyk-Jarzynka A, Radziszewski P, Gajewski Z, Paczek L.
Stem Cell Res Ther. 2018 Sep 21
https://www.ncbi.nlm.nih.gov/pubmed/30241573
Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment.
Pilch Z, Tonecka K, Braniewska A, Sas, Skorzynski M, Boon L, Golab J, Meyaard L, Rygiel TP.
Cancer Immunol Res. 2018 Aug
https://www.ncbi.nlm.nih.gov/pubmed/30021725
Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy.
Domagala A, Fidyt K, Bobrowicz M, Stachura J, Szczygiel K, Firczuk M.
Int J Mol Sci. 2018 Aug 1
https://www.ncbi.nlm.nih.gov/pubmed/30071644
Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant Recipients.
Bujnowska A, Michon M, Konopelski P, Hryniewiecka E, Jalbrzykowska A, Perkowska-Ptasinska A, Cieciura T, Zagozdzon R, Paczek L, Ciszek M.
Transplant Proc. 2018 Jul - Aug
https://www.ncbi.nlm.nih.gov/pubmed/29961551
Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells.
Chlebowska-Tuz J, Sokolowska O, Gaj P, Lazniewski M, Firczuk M, Borowiec K, Sas-Nowosielska H, Bajor M, Malinowska A, Muchowicz A, Ramji K, Stawinski P, Sobczak M, Pilch Z, Rodziewicz-Lurzynska A, Zajac M, Giannopoulos K, Juszczynski P, Basak GW, Plewczynski D, Ploski R, Golab J, Nowis D.
FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy.
Pyrzynska B, Dwojak M, Zerrouqi A, Morlino G, Zapala P, Miazek N, Zagozdzon A, Bojarczuk K, Bobrowicz M, Siernicka M, Machnicki MM, Gobessi S, Barankiewicz J, Lech-Maranda E, Efremov DG, Juszczynski P, Calado D, Golab J, Winiarska M.
Oncoimmunology. 2018 Jan 25
https://www.ncbi.nlm.nih.gov/pubmed/29721381
Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
Domagala A, Stachura J, Gabrysiak M, Muchowicz A, Zagozdzon R, Golab J, Firczuk M.
BMC Cancer. 2018 Feb 20
https://www.ncbi.nlm.nih.gov/pubmed/29463237
Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.
Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte J, Malmberg KJ.
Cancer Immunol Res. 2018 Feb 19
https://www.ncbi.nlm.nih.gov/pubmed/29459477
Application of Genome Editing Techniques in Immunology.
Zych A, Bajor M, Zagozdzon R.
Arch Immunol Ther Exp (Warsz). 2018 Jan 17
https://www.ncbi.nlm.nih.gov/pubmed/29344676
Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma.
Mazur M, Olczak J, Olejniczak S, Koralewski R, Czestkowski W, Jedrzejczak A, Golab J, Dzwonek K, Dymek B, Sklepkiewicz PL, Zagozdzon A, Noonan T, Mahboubi K, Conway B, Sheeler R, Beckett P, Hungerford WM, Podjarny A, Mitschler A, Cousido-Siah A, Fadel F, Golebiowski A.
J Med Chem. 2018 Jan 11
https://www.ncbi.nlm.nih.gov/pubmed/29283260
Photochemical delivery of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity.
Norum OJ, Fremstedal ASV, Weyergang A, Golab J, Berg K.
J Control Release. 2017 Dec 28
https://www.ncbi.nlm.nih.gov/pubmed/29042319
Discovery of selective, orally bioavailable inhibitor of mouse chitotriosidase.
Mazur M, Bartoszewicz A, Dymek B, Salamon M, Andryianau G, Kowalski M, Olejniczak S, Matyszewski K, Pluta E, Borek B, Stefaniak F, Zagozdzon A, Mazurkiewicz M, Koralewski R, Czestkowski W, Piotrowicz M, Niedziejko P, Gruza MM, Dzwonek K, Golebiowski A, Golab J, Olczak J.
Bioorg Med Chem Lett. 2017 Dec 22
https://www.ncbi.nlm.nih.gov/pubmed/29292229
Oxidative Stress in Kidney Diseases: The Cause or the Consequence?
Krata N, Zagożdżon R, Foroncewicz B, Mucha K.
Arch Immunol Ther Exp (Warsz). 2017 Dec 6
https://www.ncbi.nlm.nih.gov/pubmed/29214330
In vivo imaging system for explants analysis-A new approach for assessment of cell transplantation effects in large animal models.
Zarychta-Wiśniewska W, Burdzinska A, Zagozdzon R, Dybowski B, Butrym M, Gajewski Z, Paczek L.
PLoS One. 2017 Sep 20
https://www.ncbi.nlm.nih.gov/pubmed/28931067
The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.
Mroczek S, Chlebowska J, Kuliński TM, Gewartowska O, Gruchota J, Cysewski D, Liudkovska V, Borsuk E, Nowis D, Dziembowski A.
Nat Commun. 2017 Sep 20
https://www.ncbi.nlm.nih.gov/pubmed/28931820
Selection of an optimal promoter for gene transfer in normal B cells.
Winiarska M, Nowis D, Firczuk M, Zagozdzon A, Gabrysiak M, Sadowski R, Barankiewicz J, Dwojak M, Golab J.
Mol Med Rep. 2017 Sep 16
https://www.ncbi.nlm.nih.gov/pubmed/28713922
Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice.
Muchowicz A, Wachowska M, Stachura J, Tonecka K, Gabrysiak M, Wołosz D, Pilch Z, Kilarski WW, Boon L, Klaus TJ, Golab J.
Eur J Cancer. 2017 Sep
https://www.ncbi.nlm.nih.gov/pubmed/28709135
HDAC6 inhibition up-regulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.
Bobrowicz M, Dwojak M, Pyrzynska B, Stachura J, Muchowicz A, Berthel E, Dalla Venezia N, Kozikowski M, Siernicka M, Miazek N, Zapala P, Domagala A, Bojarczuk K, Malenda A, Barankiewicz J, Graczyk-Jarzynka A, Zagozdzon A, Gabrysiak M, Diaz JJ, Karp M, Lech-Maranda E, Firczuk M, Giannopoulos K, Efremov DG, Laurenti L, Baatout D, Frenzel L, Malinowska A, Slabicki M, Zenz T, Zerrouqi A, Golab J, Winiarska M.
Blood. 2017 Aug 22
https://www.ncbi.nlm.nih.gov/pubmed/28830887
New insights into redox homeostasis as a therapeutic target in B-cell malignancies.
Graczyk-Jarzynka A, Zagozdzon R, Muchowicz A, Siernicka M, Juszczynski P, Firczuk M.
Curr Opin Hematol. 2017 Jul 24
https://www.ncbi.nlm.nih.gov/pubmed/28402987
Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen.
Lechowicz U, Gambin T, Pollak A, Podgorska A, Stawinski P, Franke A, Petersen BS, Firczuk M, Oldak M, Skarzynski H, Ploski R.
Scie Rep. 2017 May 31
https://www.ncbi.nlm.nih.gov/pubmed/28566687
The Anatomy of Caprine Female Urethra and Characteristics of Muscle and Bone Marrow Derived Caprine Cells for Autologous Cell Therapy Testing.
Burdzinska A, Dybowski B, Zarychta-Wisniewska W, Kulesza A, Zagozdzon R, Gajewski Z, Paczek L.
Anat Rec (Hoboken). 2017 Mar
https://www.ncbi.nlm.nih.gov/pubmed/27741564
Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles.
Sharma D, Al-Khalidi R, Edgar S, An Q, Wang Y, Young C, Nowis D, Gorecki DC.
Gene Ther. 2017 Feb 24
https://www.ncbi.nlm.nih.gov/pubmed/28004656
Dissection of CD20 regulation in lymphoma using RNAi.
Słabicki M, Lee KS, Jethwa A, Sellner L, Sacco F, Walther T, Hüllein J, Dietrich S, Wu B, Lipka DB, Oakes CC, Mamidi S, Pyrzyńska B, Winiarska M, Oleś M, Seifert M, Plass C, Kirschfink M, Mann M, Boettcher M, Golab J, Huber W, Fröhling S, Zenz T.
Leukemia. 2016 Aug 18
http://www.ncbi.nlm.nih.gov/pubmed/27560109
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199.
Bojarczuk K, Sasi BK, Gobessi S, Innocenti I, Pozzato G, Laurenti L, Efremov DG.
Blood. 2016 Jun 23
http://www.ncbi.nlm.nih.gov/pubmed/27095788
MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.
Polak A, Kiliszek P, Sewastianik T, Szydłowski M, Jabłońska E, Białopiotrowicz E, Górniak P, Markowicz S, Nowak E, Grygorowicz MA, Prochorec-Sobieszek M, Nowis D, Gołąb J, Giebel S, Lech-Marańda E, Warzocha K, Juszczyński P.
PLoS One. 2016 May 19
http://www.ncbi.nlm.nih.gov/pubmed/27196001
The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development.
Stachura J, Wachowska M, Kilarski WW, Güç E, Golab J, Muchowicz A.
Oncoimmunology. 2016 May 13
http://www.ncbi.nlm.nih.gov/pubmed/27622039
An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein.
Bajor M, Zaręba-Kozioł M, Zhukova L, Goryca K, Poznański J, Wysłouch-Cieszyńska A.
PLoS One. 2016 May 9
http://www.ncbi.nlm.nih.gov/pubmed/27159591
Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo.
Gabrysiak M, Wachowska M, Barankiewicz J, Pilch Z, Ratajska A, Skrzypek E, Winiarska M, Domagala A, Rygiel TP, Jozkowicz A, Boon L, Golab J, Firczuk M.
Oncol Rep. 2016 Apr 1
http://www.ncbi.nlm.nih.gov/pubmed/27035643
Investigation of cell death mechanisms in human lymphatic endothelial cells undergoing photodynamic therapy.
Wachowska M, Osiak A, Muchowicz A, Gabrysiak M, Domagała A, Kilarski WW, Golab J.
PhotodiagnosisPhotodynTher. 2016 Feb 8.
http://www.ncbi.nlm.nih.gov/pubmed/26868051
Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.
Trzeciecka A, Klossowski S, Bajor M, Zagozdzon R, Gaj P, Muchowicz A, Malinowska A, Czerwoniec A, Barankiewicz J, Domagala A, Chlebowska J, Prochorec-Sobieszek M, Winiarska M, Ostaszewski R, Gwizdalska I, Golab J, Nowis D, Firczuk M.
Oncotarget. 2016 Jan 12;7(2):1717-31. doi: 10.18632/oncotarget.6435.
http://www.ncbi.nlm.nih.gov/pubmed/26636537/